95% of the inflammation is gone
Specifically, tirzepatide was associated with a 50% reduced risk of POAG, 26% reduced risk of OHT and 41% reduced risk of requiring new glaucoma treatment
Best Candidates: Men & women with dull skin, pigmentation, melasma, uneven tone, oxidative damage, or weakened immunity Anaesthesia Used: None required (painless IV administration) Treatment Duration: 2030 minutes per infusion Hospital Stay: Not required (performed in a medical-grade clinic) Downtime: Zero downtime
In clinical practice, providers typically conduct a trial period (usually 1216 weeks) to assess the effectiveness of the therapy, recommending cessation if weight loss is insufficient (40)
Thankfully, discontinuing semaglutide doesnt have to be the end of your weight loss journey